title: Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.
authors.forename: Keisuke
authors.initials: K
authors.lastname: Nishimura
authors.forename: Jun
authors.initials: J
authors.lastname: Saegusa
authors.forename: Seiji
authors.initials: S
authors.lastname: Kawano
authors.forename: Akio
authors.initials: A
authors.lastname: Morinobu
mesh_terms: D000068879:Adalimumab; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D005921:Glomerulonephritis / Q000139:chemically induced*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab